Patient reported outcomes in a trial of combination therapy with etanercept and methotrexate for rheumatoid arthritis: the TEMPO trial

OBJECTIVE: To compare patient reported measures of function, health related quality of life (QoL), and satisfaction with medication among patients with rheumatoid arthritis (RA) treated with methotrexate (MTX), etanercept, or both for up to 1 year. METHODS: In a 52 week, double blind, clinical trial...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: van der Heijde, D, Klareskog, L, Singh, A, Tornero, J, Melo‐Gomes, J, Codreanu, C, Pedersen, R, Freundlich, B, Fatenejad, S
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BMJ Group 2006
Gaiak:
Extended Report
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC1798055/
https://ncbi.nlm.nih.gov/pubmed/16079172
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.2005.035709
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak